0001193805-25-000923.txt : 20250620 0001193805-25-000923.hdr.sgml : 20250620 20250620171545 ACCESSION NUMBER: 0001193805-25-000923 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250604 FILED AS OF DATE: 20250620 DATE AS OF CHANGE: 20250620 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vitt Daniel CENTRAL INDEX KEY: 0001773673 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36201 FILM NUMBER: 251062299 MAIL ADDRESS: STREET 1: IMMUNIC AG STREET 2: AM KLOPFERSPITZ 19 CITY: MARTINSRIED STATE: 2M ZIP: 82152 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNIC, INC. CENTRAL INDEX KEY: 0001280776 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 562358443 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1200 AVENUE OF THE AMERICAS STREET 2: SUITE 200 CITY: NEW YORK STATE: X1 ZIP: 10036 BUSINESS PHONE: (332) 255-9818 MAIL ADDRESS: STREET 1: 1200 AVENUE OF THE AMERICAS STREET 2: SUITE 200 CITY: NEW YORK STATE: X1 ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: VITAL THERAPIES INC DATE OF NAME CHANGE: 20040219 4/A 1 e664638_4a-vitt.xml X0508 4/A 2025-06-04 2025-06-06 0 0001280776 IMMUNIC, INC. IMUX 0001773673 Vitt Daniel 1200 AVENUE OF THE AMERICAS, SUITE 200 NEW YORK NY 10036 1 1 0 0 CEO and Director 0 Common Stock 2025-06-04 4 P 0 15000 0.77 A 29000 D Common Stock 362877 I See footnote Stock Option 0.7729 2025-06-05 4 A 0 1558000 0.00 A 2035-06-05 Common Stock 1558000 1558000 D The purchase was made in Euros and the price was converted into U.S. dollars based on the foreign currency exchange rate as of June 4, 2025 (at Euro 1.00 = U.S. dollar 1.1384). 362,877 shares of the Issuer's common stock are owned by Listrax UG (haftungsbeschrankt). The RP is Managing Director of Listrax UG and exercises voting and dispositive power over such shares. 25% of the shares underlying the option vest on the first anniversary of the grant date, with the remainder vesting in equal increments on each successive one-month anniversary thereafter for the next 36 months. This Form 4/A is being filed to amend the prior Form 4 filed by the Reporting Peron on June 6, 2025 to correct an administrative error that incorrectly reported the number of stock options granted. /s/ Daniel Vitt 2025-06-20